Preferential allocation of marginal kidney allografts to elderly recipients combined with modified immunosuppression gives good results

Transplantation

Volumn 80, Issue 7, 2005, Pages 953-958

  Segoloni, Giuseppe Paolo ^a   Messina, Maria ^a   Squiccimarro, Giuseppe ^a   Mazzucco, Gianna ^b   Torta, Elisa ^a   Leonardi, Gianluca ^a   Fop, Fabrizio ^a   Roggero, Stefano ^c   Vigotti, Federica ^a   Piccoli, Giorgina B ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Department of Genetics   (Italy)

Author keywords

Elderly; Immunosuppression; Kidney allocation; Marginal donors; Renal transplantation

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ADULT; AGED; ARTICLE; CREATININE CLEARANCE; DRUG WITHDRAWAL; ELDERLY CARE; GRAFT REJECTION; GRAFT SURVIVAL; HAZARD ASSESSMENT; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; MAINTENANCE THERAPY; NEPHROTOXICITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RESOURCE ALLOCATION;

AGED; CADAVER; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; KIDNEY; KIDNEY TRANSPLANTATION; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 27644528849     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000174134.80947.0A     Document Type: Article

References (24)

1. Kruger B, Zulke C, Fischereder M, et al. Early experience with the ET senior Program "Old for Old", better to be number one? Transpt Int 2002; 15: 541.
2. Beckurts UTE, Stippel D, Pollok M, et al. Single center experience with the "Old for Old" program for renal transplantation. Transplant Proc 2001; 33: 3779.
3. Suarez JF, Riera LI, Franco E, et al. Preservation of kidneys from marginal donors with pulsatile perfusion machine. Transplant Proc 1999; 31: 2292.
4. Grinyò JM. for the BN 52021 Study group in renal transplantation: BN52021: a platetelet activating factor antagonist for preventing post transplant renal failure. A double blind randomised study. Ann Intern Med 1994; 57: 211.
5. Theodorakis J, Schneeberger H, Illner W-D, et al. Nephrotoxicity-free, Mycophenolate Mofetil-base induction/maintenance immunosuppression in elderly recipients of renal allografts from elderly cadaveric donors. Transplant Proc 2000; 32: 9S.
6. Grinyo JM, Gil-Vernet S, Seroin D, et al. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft. Nephrol Dial Transplant 1998; 13: 2601.
7. Meier-Kriesche H-U, Ojo A, Hanson J, et al. Increased immunosuppressive vulnerability in elderly renal recipients. Transplantation 2000; 69: 885.
8. Meier-Kriesche H-U. Exponentially increased risk of infectious death in older renal transplant recipients. Kidney Int 2001; 59: 1539.
9. Ponticelli C. Should renal transplantation be offered to older patients? Nephrol Dial Transplant 2000; 15: 315.
10. Shapiro R, Jordan M, et al. Scantlebury FK 506 in clinical kidney transplantation. Transplant Proc 1991; 23: 3065.
11. Boots JM, Christiaans MH, van Duijnhoven EM, et al. Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study. Transplantation 2002; 74: 1703.
12. Karpinsky J, Lajoie G, Cattran D, et al. Outcome of kidney transplantation from high risk donor is determined by both structure and function. Transplantation 1999; 67: 1162.
13. Pascual J, Liaño F, and the Madrid Acute Renal Failure Study Group. Causes and prognosis of acute renal failure in the very old. J Am Geriatr Soc 1998; 46: 721.
14. Grinyò JM. Borderline kidney graft donors- what are the problems? Nephrol Dial Transplant 2000; 15: 950.
15. Cecka JM, Terasaki Pi The UNOS Scientific Transplant Registry-1991. Clin Transpl 1991; 1: 1.
16. Report AIRT 2003;2004:29 2004 Editrice Compositori 40128 Bologna (Italy).
17. Shaffer D, Langone A, Nylander WA, et al. A pilot protocol of a calcineurin - inhibitor free-regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function. Clin Transpl 2003; 17: (Suppl 9): 31.
18. Cantarovich D, Baatard R, Barangere T, et al. Cadaveric renal transplantation after 60 years of age. A single center experience. Transpl Int 1994; 7: 33.
19. Tesi RJ, Elkhammas EA, Davies EA, et al. Renal transplantation in older people. Lancet 1994; 343: 461.
20. EBPG Expert Group on Renal Transplantation European best practice guidelines for renal transplantation: Section IV: long term management of the transplant recipient IV. 12 Elderly (specific problems). Nephrol Dial Transplant 2002; 17 Suppl 4: 58.
21. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001; 13: 114.
22. de Fijter JW, Mallat Mj, Doxiadis II, et al. Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol 2001; 12: 1538.
23. Emparan C, Laukotter M, Wolters H, et al. Calcineurin -free protocols with Basiliximab induction allow patients included in "old to old" program achieve standard kidney transplant function. Transplant Proc 2003; 35: 1326.
24. Meier-Kriesche HU, Kaplan B. Immunosuppression in elderly renal transplant recipients. Are current regimens to aggressive? Drugs Aging 2001; 18: 751.